Bibliographic Details
| Title: |
REMIX Study: Ixa-Len-Dex for Relapsed/Refractory Myeloma |
| Authors: |
By:Vivian G. Oehler, MD |
| Source: |
CancerNetwork (USA), September 26, 2023 News, 4pp |
| Abstract: |
EP: 1.Team Introductions: MM Experts From the Fred Hutchinson Cancer Center and City of Hope EP: 2.Biochemical and Clinical Progression: The Two Faces of Relapsed MM EP: 3.Cross Q&A: Navigating Biochemical Relapse and MRD Resurgence in Multiple Myeloma EP: 4.Cross Q&A: Balancing Progression and Lines of Therapy at Myeloma Relapse Now Viewing EP: 5.REMIX Study: Ixa-Len-Dex for Relapsed/Refractory Myeloma EP: 6.Cross Q&A: Exploring the Role of Ixazomib in Relapsed/Refractory Multiple Myeloma EP: 7.Ixa-Pom-Dex as Second-Line Therapy in Relapsed/Refractory MM: Alliance A061202 EP: 8.Debate on Efficacy and Patient Selection With Ixa-Pom-Dex in Relapsed/Refractory MM... |
| Database: |
NewsBank |
